Posted 02 September, 2022
bioAffinity Technologies, Inc. IPO completed
IPO completed detected for ticker Nasdaq:BIAF in a 424B4 filed on 02 September, 2022.
This is the initial public offering (the "Offering") of 1,282,600 units (each, a "Unit," collectively, the "Units").
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of bioAffinity Technologies, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.Market Cap
$22.3M
View Company Details
$22.3M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.